CNO Financial Group, Inc.
NYSE:CNOInsurance - Life
+$0.03 today
- Market cap
- $5.14B
- Beta
- 0.84
- P/E (TTM)
- 19.6
- EPS (TTM)
- $2.61
- Dividend yield
- 1.35%
Volume 0.67M
Average 0.71M
CNO Accounts Receivables
Cash effect of the change in amounts owed by customers; growing receivables consume cash.
CNO Financial Group, Inc.NYSE: CNO
Accounts Receivables · Q2 FY2026 · quarter ended Jun 2026
Accounts receivables outflow grows to $0
Q2 FY2026 accounts receivables was $0, compared with $0 a year earlier. Trailing-twelve-month accounts receivables was $0.
Context
- Accounts receivables amounted to 0.0% of revenue in FY2025, unchanged from a year earlier.
- Accounts receivables increased in 0 of the last 3 fiscal years.
- FY2025 was the highest annual figure in the 4 fiscal years shown.
What to watch
Whether quarterly accounts receivables holds near $0 or moves back toward the trailing-twelve-month quarterly average of $0.
Sources:Cash FlowText generated from reported figures; not investment advice.
Accounts Receivables history
USD · from the cash flow
- Latest · FY2025
- 0 USD
- Year-over-year change
- —
| Period | Period end | Accounts Receivables | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 0 | — |
| FY2024 | 2024-12-31 | 0 | — |
| FY2023 | 2023-12-31 | 0 | — |
| FY2022 | 2022-12-31 | 0 | — |
| FY2021 | 2021-12-31 | 0 | — |
Accounts Receivables vs competitors
How CNO compares with its peers on the latest reported figures
- CNO's LTM Jun 2026 accounts receivables of $0 is the 6th largest of the 9 companies compared; the peer median is $0.
- Accounts receivables amounts to 0.0% of revenue for CNO, versus a peer median of 0.1%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Sep 2026 | $17.82M | -123.0% | +31.4% | 0.9% | |
| LTM Sep 2026 | $12.94M | +468.4% | — | 1.9% | |
| LTM Jun 2026 | $8M | +700.0% | — | 0.1% | |
| LTM Jun 2026 | $4.25M | -4.4% | — | 0.2% | |
| LTM Jun 2026 | $34K | -103.1% | — | 0.0% | |
| LTM Jun 2026 | $0 | — | — | 0.0% | |
| LTM Sep 2026 | $0 | +100.0% | — | 0.0% | |
| LTM Jun 2026 | $0 | — | — | 0.0% | |
| LTM Sep 2026 | $0 | +100.0% | — | 0.0% | |
| Peer median (excluding CNO) | $0 | +100.0% | +31.4% | 0.1% | |
Competitors are the stored peer set for CNO. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Cash Flow Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Net Income | 570.3M | 630.6M | 276.5M | 404M | 229.3M |
| Depreciation & Amortization | 236.6M | 248.5M | 267.4M | 292.4M | 318.5M |
| Deferred Income Tax | 146.5M | 152M | 21.1M | 59.1M | 26.3M |
| Stock-Based Compensation | 25.2M | 0 | 0 | 0 | 0 |
| Change in Working Capital | 346.2M | (374.7M) | 449.7M | 556.3M | 618.1M |
| Accounts Receivables | 0 | 0 | 0 | 0 | 0 |
| Inventory | 0 | 0 | 0 | 0 | 0 |
| Accounts Payables | 0 | 0 | 0 | 0 | 0 |
| Other Working Capital | 346.2M | (374.7M) | 449.7M | 556.3M | 618.1M |
| Other Non-Cash Items | (726.5M) | (161M) | (431.8M) | (684.1M) | (516.5M) |
| Operating Cash Flow | 598.3M | 495.4M | 582.9M | 627.7M | 675.7M |
| Capital Expenditures | 0 | 0 | 0 | 0 | 0 |
| Acquisitions (Net) | 0 | 0 | 0 | 0 | 0 |
| Purchases of Investments | (6.15B) | (6.52B) | (3.62B) | (6.89B) | (8.46B) |
| Sales of Investments | 4.7B | 4.8B | 2.79B | 5.42B | 6.8B |
| Other Investing Activities | (75.3M) | (61.2M) | (36.6M) | (13.5M) | (3.2M) |
| Investing Cash Flow | (1.53B) | (1.78B) | (872.3M) | (1.49B) | (1.67B) |
| Debt Repayment | 68M | (120.7M) | 258.7M | 370M | (469.6M) |
| Common Stock Issued | 21.5M | 13.5M | 13.2M | 11.2M | 11.6M |
| Common Stock Repurchased | (407.8M) | (190.1M) | (166.1M) | (300.2M) | (331.4M) |
| Dividends Paid | (65.7M) | (64.8M) | (68.1M) | (67.7M) | (66.2M) |
| Other Financing Activities | 1.05B | 1.56B | 495.8M | 1.96B | 833M |
| Financing Cash Flow | 667.6M | 1.2B | 533.5M | 1.97B | (22.6M) |
| Effect of Forex Changes | 0 | 0 | 0 | 0 | 0 |
| Net Change in Cash | (260.2M) | (86.8M) | 244.1M | 1.11B | (1.01B) |
| Free Cash Flow | 598.3M | 495.4M | 582.9M | 627.7M | 675.7M |
CNO Financial Group, Inc.
NYSE:CNO
Intrinsic Alpha fair value
Locked
Current Price
$56.32
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.